Evaluation of a novel Cardiac Peri-Operative Transfusion Trigger Scoring system in patients with coronary artery...

Area of Science:

• Cardiology
• Transfusion Medicine
• Health Economics

Background:

• A need exists for a precise scoring system to manage perioperative blood transfusions in coronary artery disease (CAD) patients undergoing cardiac surgery.
• Current transfusion guidelines may not be optimal for this specific patient population.
• This study evaluated a novel scoring strategy for transfusion decisions in CAD patients.

Purpose of the Study:

• To assess the safety and efficacy of the Cardiac Peri-Operative Transfusion Trigger Score (cPOTTS) system.
• To compare transfusion requirements and red blood cell (RBC) consumption between the cPOTTS group and a conventional group.
• To determine the impact of the cPOTTS system on patient outcomes and healthcare costs.

Main Methods:

• A multicenter randomized controlled trial involving 500 patients (254 in cPOTTS group, 246 in conventional group) from January 2015 to May 2018.
• Comparison of transfusion needs and per capita RBC consumption between the cPOTTS and conventional groups.
• Analysis of primary outcomes (1-year mortality, perioperative ischemic cardiac events) and secondary outcomes (shock, infections, renal impairment).

Main Results:

• No significant differences in primary or secondary clinical outcomes between the cPOTTS and conventional groups.
• Patients in the cPOTTS group experienced significantly shorter hospital stays.
• The cPOTTS group demonstrated lower hospital costs, reduced RBC utilization rates, and lower per capita RBC consumption.

Conclusions:

• The novel cPOTTS scoring system provides a practical and simple guideline for perioperative blood transfusion in CAD patients.
• The cPOTTS system effectively reduces blood product usage and healthcare costs.
• This scoring strategy is safe and efficacious for guiding transfusion decisions in cardiac surgery patients with CAD.